Association of dopamine D
D(2/3)
Dopamine
[(11)C]-(+)-PHNO
mRNA
Journal
NeuroImage
ISSN: 1095-9572
Titre abrégé: Neuroimage
Pays: United States
ID NLM: 9215515
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
05
05
2020
revised:
12
08
2020
accepted:
12
08
2020
pubmed:
21
8
2020
medline:
4
3
2021
entrez:
21
8
2020
Statut:
ppublish
Résumé
Open access post-mortem transcriptome atlases such as the Allen Human Brain Atlas (AHBA) can inform us about mRNA expression of numerous proteins of interest across the whole brain, while in vivo protein binding in the human brain can be quantified by means of neuroreceptor positron emission tomography (PET). By combining both modalities, the association between regional gene expression and receptor distribution in the living brain can be approximated. Here, we compare the characteristics of D
Identifiants
pubmed: 32818617
pii: S1053-8119(20)30756-4
doi: 10.1016/j.neuroimage.2020.117270
pmc: PMC7610745
mid: EMS123381
pii:
doi:
Substances chimiques
Carbon Radioisotopes
0
Carbon-11
0
Dopamine Agonists
0
RNA, Messenger
0
Receptors, Dopamine D2
0
Receptors, Dopamine D3
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
117270Subventions
Organisme : Austrian Science Fund FWF
ID : DOC 33
Pays : Austria
Organisme : Austrian Science Fund FWF
ID : KLI 516
Pays : Austria
Organisme : Austrian Science Fund FWF
ID : P 23585
Pays : Austria
Informations de copyright
Copyright © 2020. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of Competing Interest Without relevance to this work, Matthäus Willeit declares to having received speaker honoraria and consulting fees from Janssen-Cilag Pharma GmbH, Austria. Wolfgang Wadsak declares to having received speaker honoraria from GE Healthcare, research grants from Ipsen Pharma, Eckert-Ziegler AG, Scintomics and ITG. He is a part time employee of CBmed Ltd (Center for Biomarker Research in Medicine, Graz, Austria). Marcus Hacker received consulting fees and/or honoraria from Bayer Healthcare BMS, Eli Lilly, EZAG, GE Healthcare, Ipsen, ITM, Janssen, Roche, Siemens Healthineers. Rupert Lanzenberger received travel grants and/or conference speaker honoraria within the last three years from Bruker BioSpin MR, Heel, and support from Siemens Healthcare regarding clinical research using PET/MR. Siegfried Kasper received grants/research support, consulting fees and/or honoraria within the last three years from Angelini, AOP Orphan Pharmaceuticals AG, Celegne GmbH, Eli Lilly, Janssen-Cilag Pharma GmbH, KRKA-Pharma, Lundbeck A/S, Mundipharma, Neuraxpharm, Pfizer, Sanofi, Schwabe, Servier, Shire, Sumitomo Dainippon Pharma Co. Ltd. and Takeda. Arkadiusz Komorowski, Ana Weidenauer, Martin Bauer, Ulrich Sauerzopf, Matej Murgaš, Markus Mitterhauser, and Nicole Praschak-Rieder have no conflicts of interest to declare.
Références
PLoS One. 2019 Jul 22;14(7):e0219854
pubmed: 31329615
Hum Brain Mapp. 2014 Aug;35(8):4204-18
pubmed: 24677576
Synapse. 2012 Jun;66(6):489-500
pubmed: 22213512
Eur J Pharmacol. 1992 Apr 10;225(4):331-7
pubmed: 1354163
Cereb Cortex. 2018 Sep 1;28(9):3267-3277
pubmed: 28968835
PLoS Comput Biol. 2016 Aug 26;12(8):e1005064
pubmed: 27564987
Schizophr Res. 2011 Sep;131(1-3):63-8
pubmed: 21684721
Neuroimage. 2011 Jan 1;54(1):264-77
pubmed: 20600980
Sci Data. 2018 Apr 17;5:180063
pubmed: 29664465
Endocrinology. 1985 Aug;117(2):690-7
pubmed: 4017954
Nat Neurosci. 2018 Sep;21(9):1251-1259
pubmed: 30082915
Neuroimage. 2016 Apr 15;130:241-247
pubmed: 26876475
Synapse. 1993 Aug;14(4):254-62
pubmed: 7902615
Neuropsychopharmacology. 2014 Jan;39(2):311-8
pubmed: 23921256
FEBS Lett. 2018 Jun;592(12):2012-2022
pubmed: 29754392
Science. 2015 Jun 12;348(6240):1241-4
pubmed: 26068849
Neuroimage. 2017 Mar 1;148:343-351
pubmed: 28110088
Eur Neuropsychopharmacol. 2015 Sep;25(9):1410-20
pubmed: 26141509
Appl Radiat Isot. 2013 Dec;82:75-80
pubmed: 23974301
J Cereb Blood Flow Metab. 2002 Dec;22(12):1440-52
pubmed: 12468889
J Neurosci. 2012 Jan 25;32(4):1353-9
pubmed: 22279219
Neuroimage. 2019 Apr 1;189:353-367
pubmed: 30648605
Biol Psychiatry. 2006 Mar 1;59(5):389-94
pubmed: 16373068
J Med Chem. 2005 Jun 16;48(12):4153-60
pubmed: 15943487
Synapse. 2007 May;61(5):263-7
pubmed: 17318886
Proc Natl Acad Sci U S A. 2016 May 17;113(20):E2861-70
pubmed: 27114539
Int J Neuropsychopharmacol. 2010 Apr;13(3):273-87
pubmed: 19751545
Brain Res. 1998 Aug 3;800(2):269-74
pubmed: 9685676
Neuroimage. 2018 Aug 1;176:259-267
pubmed: 29723639
Pharmacol Rev. 2011 Mar;63(1):182-217
pubmed: 21303898
Hum Brain Mapp. 2007 Apr;28(4):294-302
pubmed: 16779798
Biol Psychiatry. 2012 Mar 15;71(6):561-7
pubmed: 22133268
FEBS Lett. 2009 Dec 17;583(24):3966-73
pubmed: 19850042
Nature. 2012 Sep 20;489(7416):391-399
pubmed: 22996553
Synapse. 1994 Jul;17(3):167-72
pubmed: 7974199
PLoS One. 2016 Feb 16;11(2):e0148744
pubmed: 26882227
Brain Res. 2007 Jul 2;1156:31-45
pubmed: 17509542
Neuropsychopharmacology. 2009 Mar;34(4):1078-86
pubmed: 18987627
Neuroscience. 1989;28(2):275-90
pubmed: 2522167
Neuropsychopharmacology. 2014 May;39(6):1479-89
pubmed: 24385130
Neuropsychopharmacology. 2008 Jan;33(2):279-89
pubmed: 17406650
Synapse. 2009 Sep;63(9):782-93
pubmed: 19489048
Transl Psychiatry. 2020 Jan 8;10(1):2
pubmed: 32066718
Neuroimage. 2016 Apr 15;130:1-12
pubmed: 26850512
J Cereb Blood Flow Metab. 2007 Apr;27(4):857-71
pubmed: 17033687
Synapse. 1996 Jun;23(2):115-23
pubmed: 8723716
Cereb Cortex. 2020 May 18;30(6):3771-3780
pubmed: 31989157
J Psychiatry Neurosci. 2013 Mar;38(2):98-106
pubmed: 23010256
PLoS One. 2016 Jul 19;11(7):e0159395
pubmed: 27434030
Trends Neurosci. 2012 Dec;35(12):711-4
pubmed: 23041053
J Neurochem. 2006 May;97(4):1089-103
pubmed: 16606355
Cereb Cortex. 2017 Jan 1;27(1):117-130
pubmed: 27909009
J Cereb Blood Flow Metab. 2015 Nov;35(11):1812-8
pubmed: 26058690
Biol Psychiatry. 2010 Aug 15;68(4):392-9
pubmed: 20599188